Pioneers of blood and tissue microbiome exploration, we are leaders in low bacterial biomass sample analysis

ABOUT VAIOMER
V de Voimer

Microbiome analysis for convincing data

Our contamination aware approach is crucial

By carefully controlling for contamination at every step of microbiome analysis, we provide reliable data that reflect the actual bacterial load of tissues rather than contaminants.

Mission

Vaiomer microbiome analysis stimulates the discovery

of new disease mechanisms, new biomarkers to contribute to personalized medecine, new pathways to identify novel therapeutic targets.

Microbiome analysis applications

Blood and tissue microbiota in health and diseases

Cardio - metabolic diseases

Liver diseases

Gastrointestinal disorders

Cancer

Neurodegenerative and mental disorders

COVID, HIV & infectious diseases

COVID, HIV & infectious diseases

Autoimmune and inflammatory diseases

Nutrition

Kidney diseases

Microbiome in early life

Vaiomer microbiome expertise

Exploring the circulating and tissue microbiomes

Beyond the human gut microbiome

The microbiota is not only located in the gut. It expands to every part of the body, ranging from very high to very low bacterial biomass. Learn more by travelling through our microbiome atlas.

Vaiomer tailor - made metagenomics

Challenging low bacterial biomass samples are now accessible thanks to our specifically optimized and contamination-aware metagenomic workflow. Discover our microbiome analysis services.

INNOVATORS’ EXPERIENCE

The early explorers of tissue microbiomes

Dowload our white paper

 

Learn about the gut, blood and tissue microbiota, the link between gut dysbiosis and tissue inflammation, and discover how these microbiota positively or negatively influence our physiology and can cause disease

 

News and views

VAIOMER Experts’ Highlights

Vaiomer is honored to sponsor the 8th IHMC Congress
Vaiomer will attend the 8th IHMC Congress. Join us on our virtual stand to chat about microbiomes.

Vaiomer is honored to sponsor the 8th IHMC Congress

> Vaiomer is happy to announce that we will be attending the 8th IHMC Virtual Congress 2021 on June 27, 28 & 29.
> Visit our virtual stand and come chat with us about microbiomes beyond the gut!

Vaiomer taking part in Pharmabiotics 2021
Vaiomer taking part in Pharmabiotics 2021, 28-29 april #Microbiome #BeyondTheGut #MicrobiomeScience #ClinicalResearch

Vaiomer taking part in Pharmabiotics 2021

> Join the virtual conference
> Watch our presentation “Exploring the microbiomes beyond the gut thanks to a contamination aware approach”
> Take part in our roundtable about “the Gut – Metabolic Organ – Axis: The Importance of Target Tissue Microbiomes”
> Interested in discussing the potential of Blood and Tissue Microbiomes? We welcome one to one meeting requests

FRANCE RELANCE